Genitourinary Cancer
Conference Coverage
Single and multifraction SBRT found comparable for lung metastases
A single-fraction regimen and a four-fraction regimen netted essentially the same toxicity and oncologic outcomes at 1 year of follow-up.
From the Journals
‘Tour de force’ study reveals therapeutic targets in 38% of cancer patients
The NCI-MATCH trial has led to new clinical trial benchmarks, according to the study chair.
Conference Coverage
Lower BP and better tumor control with drug combo?
From the Journals
Novel assay may better detect urothelial carcinoma
The UroCAD assay proved more sensitive than urine cytology.
Feature
Are oncologists ready to confront a second wave of COVID-19?
Conference Coverage
Durable efficacy with MK-6482 in VHL-associated RCC
MK-6482 produced responses in patients with Von Hippel-Lindau disease-associated renal cell carcinoma and non-renal lesions.
Conference Coverage
Clinical factors and treatment tied to COVID-19 mortality in cancer patients
Analyses of CCC19 data revealed factors linked to mortality in patients with COVID-19 and cancer.
Clinical Insights
The scope of under- and overtreatment in older adults with cancer
From the Journals
Cancer disparities: One of the most pressing public health issues
“The burden of cancer is not shouldered equally by all segments of the U.S. population,” the AACR states.
From the Journals
Global stomach cancer deaths decline as colorectal cancer deaths stagnate, rise
Data suggest fewer people are dying from stomach cancer, but in some countries, the risk of colorectal cancer death is increasing or declining...
From the Journals
Predicting complications of cytoreductive nephrectomy in metastatic RCC
Registry data revealed factors associated with intraoperative and postoperative complications.